AX Pharmaceutical Corp
- Manufacturer
- AX Pharmaceutical Corp
- Effective date
- 2018-06-18
- Label type
- BULK INGREDIENT
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-06-01 02:49:01
Label at a glance#
ProductAX Pharmaceutical Corp
Active ingredientLANTHANUM CARBONATE
Label structure1 sections
Label contents#
Full prescribing information#
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| cd999b70-ef95-1812-9f06-f589ecff7593 | Product name | 5 | 20251216 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 62157-606-01 | AX Pharmaceutical Corp | 500 g in 1 JAR | POWDER | 500 | 1 |
DailyMed Dashboard NDC Coverage#
Products#
Every source-derived product name is available through these pages.
- AX Pharmaceutical Corp
- LANTHANUM CARBONATE
- LANTHANUM CATION (3+)
- WATER
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 62157-606 | 62157-606-01 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| LANTHANUM CARBONATE | 490D9F069T | ACTIM |
| WATER | 059QF0KO0R | IACT |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lanthanum carbonate | LANTHANUM CARBONATE | Prasco Laboratories | bb263fe8-2bdf-4dba-807f-194f54a73654 | 2025-12-15 | Warnings, Adverse reactions | LANTHANUM CARBONATE |
| Lanthanum Carbonate | LANTHANUM CARBONATE | Ascend Laboratories, LLC | 22b07167-2b7b-42ba-9ae9-cf58c98a2ab2 | 2025-05-06 | Warnings, Adverse reactions | LANTHANUM CARBONATE |
| Lanthanum carbonate | LANTHANUM CARBONATE | Teva Pharmaceuticals USA, Inc. | e4b88992-ecb0-455b-b68c-5c4e6d3cf521 | 2025-01-30 | Warnings, Adverse reactions | LANTHANUM CARBONATE |
| Fosrenol | LANTHANUM CARBONATE | Takeda Pharmaceuticals America, Inc. | f10776b2-2c25-4343-aabe-68f302e5cb54 | 2024-12-31 | Warnings, Adverse reactions | LANTHANUM CARBONATE |
| Lanthanum Carbonate | LANTHANUM CARBONATE | Lupin Pharmaceuticals, Inc. | 91556a42-5e16-4f86-bae9-a8cdd6b182a6 | 2024-11-07 | Warnings, Adverse reactions | LANTHANUM CARBONATE |
| Lanthanum carbonate | LANTHANUM CARBONATE | Cipla USA Inc. | 1d5ff930-1189-4e96-bdfb-9fd9c2c83d1b | 2024-08-01 | Warnings, Adverse reactions | LANTHANUM CARBONATE |
| Lanthanum carbonate | LANTHANUM CARBONATE | Exelan Pharmaceuticals, Inc. | 16b0e6f5-4fc9-448c-994a-cb9dd8b03654 | 2024-08-01 | Warnings, Adverse reactions | LANTHANUM CARBONATE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
